Abstract: A system and method are provided for dynamically, automatically aligning an element within textual matter, wherein the element has a vertical extent differing from a vertical extent of surrounding text. The method comprises the step of, based upon a difference between a font size of the text font size and a vertical extent of the element, calculating a vertical offset for placing the element relative to the textual matter. The calculated vertical offset is stored for subsequently achieving a dynamic adjustment in presentation of textual matter with the element placed therein, irrespective of desired output format.

Abstract: The present invention relates to a diagnostic method for the detection of small quantities of amniotic fluid in the vagina. More specifically, the invention relates to the detection of PAMG-1 in the vagina using anti-PAMG-1 antibodies.

Abstract: A topical sustained release delivery system for delivery of antifungal agents to the finger or toenails achieving high penetration through the nails by combining the antifingal agent with a keratolytic agent and a humectant. The pharmaceutical sustained release topical preparation is provided in a varnish or spray form for treating the nail and surrounding tissues, where the active ingredient is an antifungal agent, a keratolytic agent, or preferably a combination of an antifuingal and a keratolytic agent. The composition may further comprise an antibacterial, an antiviral, an antipsoriatic agents, or combinations thereof.

Abstract: A topical sustained release delivery system for delivery of antifungal agents to the finger or toenails achieving high penetration through the nails by combining the antifungal agent with a keratolytic agent and a humectant. The pharmaceutical sustained release topical preparation is provided in a varnish or spray form for treating the nail and surrounding tissues, where the active ingredient is an antifungal agent, a keratolytic agent, or preferably a combination of an antifungal and a keratolytic agent. The composition may further comprise an antibacterial, an antiviral, an antipsoriatic agents, or combinations thereof.

Abstract: The present invention comprises an ultrasonic resonant rod waveguide-radiator with at least three cylindrical sections, one of which is an entrance section having a planar entrance surface and another of which is an exit section having a planar exit surface, and at least two sections having a variable cross-section. The cylindrical sections and sections of variable cross-section are arranged in alternating fashion and connected to each other acoustically rigidly. The dimensions of the cylindrical sections and the sections of variable cross-section are selected so that the gain of the waveguide-radiator is significantly greater than unity and the strain created by passage of ultrasonic waves through the waveguide-radiator is minimized, increasing the operational life of the waveguide-radiator and maximizing the amount of useful energy transmitted by the waveguide-radiator.

Abstract: A compound or pharmaceutically acceptable salts thereof of Formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.

Abstract: A compound of Formula (I), wherein the substituents are as defined herein, which are useful as kinase inhibitors.

Abstract: A self-heating, portable massage or therapy table is disclosed. The portable massage table comprises a cushioned pad that is comfortable for a user to sit or lie on. Preferably inside the cushioned pad is an electrical heat mechanism which heats the cushioned pad. The cushioned pad and the heat mechanisms are sectioned so that the surface can be folded. Finally, the table comprises foldable legs that support the table.

Abstract: A universal console (UC) platform for a UC device is provided. The user sets up or initializes the UC by describing his or her preferences and disabilities. The UC digests and stores this user information. Later, as the user encounters various devices and applications to be controlled, and indicates a desire to control a particular device, the device to be controlled or other source sends a canonical user interface (UI) description of the device's UI to the UC. The canonical UI description adheres to an abstract format to describe in high-level terms the functionality of the device's UI. From the canonical UI representation, the UC device is capable of recognizing (1) the action-commands to which the device responds including parameters and (2) the decisions, selections, and input the user needs to provide for the console to determine which action-commands to send and the values of the action-command parameters.

Abstract: A method to detect invalid polygons that are inputted by users using a graphical user-interface is presented. The method selects pairs of lines that are used to define the polygon and tests to determine if the lines crossover. If there are no crossovers, then the polygon is a valid polygon. If there is a pair of lines that do crossover one another, then the polygon is an invalid polygon. Such a method is useful in teaching polygons and their properties to novices and students.

Abstract: A method and system providing a client with user interface information are described. The method and system implement a set of application program interfaces for providing user interface information to a client through an accessibility system. The accessibility system includes a mechanism for transferring user interface information from a provider side to the client side and a logical tree for selectively revealing user interface information. The application program interface system includes client side application program interfaces for assisting the client in obtaining user interface information. The client side application program interfaces include an automation class, a logical element class, a raw element class, control pattern classes, and an input class. The provider side application program interfaces include a provider automation class, a provider automation interface, a raw element interface, and control pattern provider interfaces.

Abstract: The invention relates to synchronous drug delivery composition comprising a polymeric matrix which comprises hydrogel blended with a hydrophobic polymer, so as to form an erodible matrix, a drug, and, optionally, an agent which enhances intestinal drug absorption and/or an agent which inhibits intestinal drug degradation,

Abstract: The invention is directed to non-hygroscopic oral pharmaceutical compositions of a salt of valproic acid, and processes for preparing the compositions. The non-hygroscopic pharmaceutical compositions are prepared by blending a hygroscopic salt of valproic acid, carbomer, and a non-hygroscopic additive.

Abstract: A self-heating, portable massage or therapy table is disclosed. The portable massage table comprises a cushioned pad that is comfortable for a user to sit or lie on. Preferably inside the cushioned pad is an electrical heat mechanism which heats the cushioned pad. The cushioned pad and the heat mechanisms are sectioned so that the surface can be folded. Finally, the table comprises foldable legs that support the table.

Abstract: The invention relates to synchronous drug delivery composition comprising a polymeric matrix which comprises hydrogel blended with a hydrophobic polymer, so as to form an erodible matrix, a drug, and, optionally, an agent which enhances intestinal drug absorption and/or an agent which inhibits intestinal drug degradation,

Abstract: The invention is directed to non-hygroscopic oral pharmaceutical compositions of a salt of valproic acid, and processes for preparing the compositions. The non-hygroscopic pharmaceutical compositions are prepared by blending a hygroscopic salt of valproic acid, carbomer, and a non-hygroscopic additive.

Abstract: A system for the accurate measurement and control of image color density on an operating printing press. The method and apparatus control the printing of a multicolored image by controlling the amount of each of the inks used to print an image based on the color densities of each of the inks detected in printed images. The process includes controlling the positioning and linear movement of a strobe and a digital video camera across a substrate having images printed thereon; illuminating the images with a strobe; selecting and acquiring the images via a digital video camera and producing a digitized representation thereof; selecting a portion of the images; measuring and analyzing the color intensity of the selected portion of the images and producing reflective density values thereof, and storing said reflective density values in a first memory; comparing the reflective density values for the portion of the images to standard density values in a second memory for the portion of the images.

Abstract: The present invention relates to a controlled release drug delivery system comprising a drug which is susceptible to enzymatic degradation by enzymes present in the intestinal tract; and a polymeric matrix which undergoes erosion in the gastrointestinal tract comprising a hydrogel-forming polymer selected from the group consisting of (a) polymers which are themselves capable of enhancing absorption of said drug across the intestinal mucosal tissues and of inbihiting degradation of said drug by intestinal enzymes; and (b) polymers which are not themselves capable of enhancing absorption of said drug across the intestinal mucosal tissues and of inhibiting degradation of said drug by intestinal enzymes; wherein when the matrix comprises a polymer belonging to group (b) the delivery system further comprises an agent which enhances absorption of said drug across the intestinal mucosal tissues and/or an agent which inhibits degradation of said drug by intestinal enzymes and when the matrix comprises a polymer belon

Abstract: Pharmaceutical gastroretentive drug delivery systems for the controlled release of an active agent in the gastrointestinal tract are disclosed, which comprise: (a) a single- or multi-layered matrix comprising a polymer that does not retain in the stomach more than a conventional dosage form selected from (1) degradable polymers that may be hydrophilic polymers not instantly soluble in gastric fluids, enteric polymers substantially insoluble at pH less than 5.5 and/or hydrophobic polymers and mixtures thereof; (2) non-degradable polymers; and any mixtures of (1) and (2); (b) a continuous or non-continuous membrane comprising at least one polymer having a substantial mechanical strength; and (c) a drug; wherein the matrix when affixed or attached to the membrane prevents evacuation from the stomach of the delivery system for a period of time of from about 3 to about 24 hours.

Abstract: The present invention is a film formed from an acrylate blend. The preferred blend is a film comprising components (a) and (b), component (a) being an ethylene butyl acrylate copolymer (EBAC) which is less than about 95 percent percent by weight of a total weight of components (a) and (b), wherein the EBAC has a content of acrylate groups from about 8 to about 36 percent by weight of the total weight of the EBAC; and component (b) being an ethylene methyl acrylate copolymer (EMAC) which is greater than about 5 percent by weight of the total weight of components (a) and (b), wherein the EMAC has a content of acrylate groups from about 8 to about 42 percent by weight of the total weight of the EMAC.